Danhong Inhibits Oxidized Low-Density Lipoprotein–Induced Immune Maturation of Dentritic Cells via a Peroxisome Proliferator Activated Receptor <I>γ</I>–Mediated Pathway-Reference-Cited by-同舟云学术

Danhong Inhibits Oxidized Low-Density Lipoprotein–Induced Immune Maturation of Dentritic Cells via a Peroxisome Proliferator Activated Receptor γ–Mediated Pathway

Published:2012 Issue:1 Volume:119 Page:1-9
ISSN:1347-8613
Container-title:Journal of Pharmacological Sciences
language:en
Short-container-title:J Pharmacol Sci

Author:

Liu Hongying,Wang Shijun,Sun Aijun,Huang Dong,Wang Wei,Zhang Chunyu,Shi Dazhuo,Chen Keji,Zou Yunzeng,Ge Junbo

Publisher

Japanese Pharmacological Society

Subject

Pharmacology,Molecular Medicine

Reference28 articles.

1. 1 Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685–1695.

2. The immune response in atherosclerosis: a double-edged sword

3. 4 Ranjit S, Dazhu L. Potential role of dendritic cells for progression of atherosclerotic lesions. Postgrad Med J. 2006;82:573–575.

4. 5 Bauriedel G, Skowasch D, Welsch U, Luderitz B. Role of dendritic cells in specific atherosclerosis types. Eur Heart J. 2006;27:116.

5. Dendritic cells in atherosclerosis: current status of the problem and clinical relevance

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sema-3E/PlexinD1 axis modulates dendritic cell phenotypes and functions: Current status and future implications;Human Immunology;2024-07

2. Roles of PPAR activation in cancer therapeutic resistance: Implications for combination therapy and drug development;European Journal of Pharmacology;2024-02

3. Strategy for Targeting Medical Diagnosis of Cerebral Ischemia Regions by Linking Gsk-3β Antibody and RVG29 to Magnetosomes;Current Nanoscience;2023-11-16

4. Inhibition of ox‐LDL‐induced endothelial cell injury by LINC02381 knockdown through the microRNA‐491‐5p/transcription factor 7 axis;Immunity, Inflammation and Disease;2023-03

5. Chinese herbal injection for cardio-cerebrovascular disease: Overview and challenges;Frontiers in Pharmacology;2023-02-24